Delivery Order SPE2DB20D3103-SPE2DB25FM3H5
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,292.00 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a completion date of February 28, 2025. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The $4,204.24 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is a delivery order off of an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,766.81 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp also...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $10,498.49. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $26,972.38 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 13, 2024, with a completion date of June 14, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,483.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order with a firm fixed price pricing type. There is no set-aside designation mentioned. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,330.02 and a completion date of September 25, 2023. This contract is not designated as a set-aside and was awarded through full and open competition....
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The $21,852.70 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 5, 2024. The contract has no set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,887.98 and an ultimate completion date of May 14, 2024. The contract is a Delivery Order under Firm Fixed Price terms. This award is not associated with a set-aside program. Amerisourcebergen holds a...
The federal contract award described is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,860.62 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 10, 2025, with a completion date of January 13, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical...